Natasha Leighl

39PUBLICATIONS
272CO-AUTHORS
Liquid biopsiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jun 29, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.

|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|Mar 16, 2026
Circulating-tumour DNA (ctDNA) in NSCLC: mechanisms, evidence and the future of MRD detection.

Beatriz Jimenez-Munarriz, Berenice Urtecho, Mary R Rabey

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila

Pageof 7

Frequent Collaborators

15 joint publications

Nofisat Ismaila

14 joint publications

Navneet Singh

11 joint publications

Narjust Florez

10 joint publications

Dwight H Owen